HLNE vs SRPT · P/E 15, rev $759.0M vs rev $1.13B
Hamilton Lane Inc (HLNE) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Hamilton Lane Inc (HLNE) is a asset management company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported HLNE revenue for 2026-03-31 was $759.0M. Net income was $249.2M. Revenue was up 6.5% from 2025-03-31 to 2026-03-31. HLNE currently screens at market cap $4.84B and trailing P/E 14.7.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
HLNE currently screens at market cap $4.84B and trailing P/E 14.7. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the HLNE and SRPT stock pages for the full models.
Not investment advice.